Therapeutic Challenges to End-Stage Kidney Disease in a Patient with Tetralogy of Fallot | Zendy

Ken Ohara | Zendy; Tetsu Akimoto | Zendy; Takuya Miki | Zendy; Naoko Otani | Zendy; Taro Sugase | Zendy; Takahiro Masuda | Zendy; Takuya Murakami | Zendy; Toshimi Imai | Zendy; Shin’ichi Takeda | Zendy; Yukio Ando | Zendy; Shigeaki Muto | Zendy; Daisuke Nagata | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Therapeutic Challenges to End-Stage Kidney Disease in a Patient with Tetralogy of Fallot

Author(s) -

Ken Ohara,

Tetsu Akimoto,

Takuya Miki,

Naoko Otani,

Taro Sugase,

Takahiro Masuda,

Takuya Murakami,

Toshimi Imai,

Shin’ichi Takeda,

Yukio Ando,

Shigeaki Muto,

Daisuke Nagata

Publication year - 2015

Publication title -

clinical medicine insights case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.187

H-Index - 12

ISSN - 1179-5476

DOI - 10.4137/ccrep.s32121

Subject(s) - medicine , tetralogy of fallot , peritoneal dialysis , renal replacement therapy , kidney disease , dialysis , stage (stratigraphy) , intensive care medicine , surgery , heart disease , paleontology , biology

In this report, we describe the case of an end-stage kidney disease patient with tetralogy of Fallot (TOF). A 33-year-old female with TOF was admitted to our hospital with complaints of general fatigue and appetite loss probably due to uremic milieu. She was ultimately treated with peritoneal dialysis (PD) with a favorable clinical course. TOF patients with chronic kidney disease are not exceptional, although the currently available information regarding the association between TOF and renal failure severe enough to require dialysis treatment is limited. We also discuss the complex processes of how and why PD was selected as a mode of chronic renal replacement therapy in this case.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research